WAVE Life Sciences Ltd.
WVE
$13.02
-$0.33-2.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.18M | -53.85M | -50.47M | -46.88M | 29.25M |
| Total Depreciation and Amortization | 2.26M | 2.23M | 2.20M | 2.16M | 2.16M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.35M | 6.47M | 6.20M | 4.95M | 3.24M |
| Change in Net Operating Assets | 9.79M | 484.00K | -3.94M | -23.28M | -78.30M |
| Cash from Operations | -33.78M | -44.67M | -46.01M | -63.04M | -43.65M |
| Capital Expenditure | 1.00K | -248.00K | -306.00K | -165.00K | -86.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.00K | -248.00K | -306.00K | -165.00K | -86.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 392.76M | 32.69M | 11.69M | 4.16M | 35.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.94M | -- | -- | -- | -24.00K |
| Cash from Financing | 439.70M | 32.69M | 11.69M | 4.16M | 34.98M |
| Foreign Exchange rate Adjustments | -60.00K | -29.00K | 43.00K | 58.00K | -103.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 405.86M | -12.25M | -34.58M | -58.99M | -8.86M |